Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$80,000,000 past due and no way to pay.
isn't that all that matters?
does a paulson raise of $15m that burns 169,000,000 pay off debt? NOPE
does a paulson raise of $15m that burns 169,000,000 shares pay for trials? NOPE
tell us, please, how the debt will be paid.
tell us, please, how they will pay for trials.
they CAN NOT PAY THE DEBT. which means they CAN NOT GET A PARTNERSHIP.
up to $80,000,000 can be seized by the courts. no partner will come. no venture capital.
no bank loan. no active stake. NO MEANINGFUL FUNDING IS POSSIBLE.
$5m in cash remains. 80m shares remain. 500,000,000 new shares will be requested soon.
lol no NON-DILUTIVE and/or MEANINGFUL funding is possible. massive debt precludes this. courts can seize up to $100,000,000 at any time, so please, list the potential sources of funding for me. they will report less than $5m cash in hand and less than 80m shares available in their next 10q in april. they essentially have no cash and no shares. NOW WHAT???
paulson placement=unmitigated disaster @ NINE CENTS PER SHARE. they raised $15m net burning 169,000,000 shares. that is unsustainable and leads them towards bankruptcy.
when a company says "EXPECT", that is a common "forward looking statement" which requires a disclaimer under SEC regulations. the disclaimer for Arman's purposely misleading forward statement is on page TWO of the presentation that includes the page NINETY-NINE forward looking statement: "EXPECT funding". companies are protected from lawsuits as long as they disclaim their forward looking statements in writing. and because of that, otcs are famous for misleading investors via forward looking statements. Nader used that trick constantly and Arman has been doing the same. When you are in massive debt and have no way to raise necessary funds even for payroll given the very low valuations, then there isn't much of a choice beyond deception. If Arman comes on the quarterly call and says "we honestly don't know how we are ever going to pay down the debt. our options are extremely limited and at this juncture we haven't had any partnership interest despite contacting most of the top 50 big pharmas. we really need MD Anderson to come through or else we may not be able to move forward and bankruptcy proceedings may be necessary", then the share price plummets and layoffs are required and the company is done. he therefore has no choice but to feed you vague misleading forward statements in order to avoid a share price collapse and likely bankruptcy.
no sane person EXPECTS funding for cytodyn in 2023. anyone stating so is trying to mislead you. cytodyn has MORE THAN $80,000,000 in unpaid PAST DUE debt and perhaps $100,000,000 contractually subject to injunctive relief. that means that any time cytodyn has any significant funds available, creditors can go to court and be granted an injunction to freeze those assets and then sue to recover the defaulted debt. that means if anyone were to gift grant loan or otherwise make available any funds to cytodyn, those funds would be flushed right down the toilet. no entity on earth is gong to present cytodyn with $10s of millions of dollars that will be immediately redirected to creditors.
cytodyn has perhaps $100,000,000 in past due debt SUBJECT TO LEGAL SEIZURE. there will be no outside funding, via partnership or any other method, as long as any amount up to $100,000,000 is subject to seizure. could anything possibly be any clearer than that? They have documented more than $80,000,000 is past de debt and more has come to light recently. the full extent of the past due debt is not known.
The 2 1000% disqualifyng matters that i listed that absolutely prevent cytodyn from any hope of partnership for several years are just 2 of many such red flags. And even those 2 have additional levels to them. Heck, not only has the current skeleton crew management team never completed a trial together, NONE OF THE 3 HAVE EVER MADE SIGNIFICANT CONTRIBUTIONS TO ANY TRIAL AT ANY COMPANY. none of the 3 have ever worked on therapeutic teams. The CEO has only had 8 years TOTAL pharma employment for cripes sake. 2 short timer joke positions and 1 legit run for just 5 years at Amgen as a mid level manager. He has never been anywhere near CEO material. The other 2 were mainly project managers in CMC and Materials areas. SUPPLY CHAIN! Meidling briefly did a bit of preclinical support.
NONE OF THEM have ever worked directly on FDA regulatory filings! How can you partner with a "team" of 3 with no direct experience whatsoever in therapeutic development???
looking deeper at the financial nightmare... not only does cytodyn potentially face up to $100,000,000 in injunctive relief - they also have NO SUSTAINABLE FUNDING METHODS even for meeting PAYROLL! How can you partner with a company that can't even meet its payroll???
All they have for funding are 1) private placements and 2) induced warrant conversions. that is atrocious. the latest placement raised funds at a rate of NINE CENTS PER SHARE!!! and they are down to less than 80m shares after burning 570m in 15 months! there is no partner interest whatsoever.
you say Arman "seems to have a plan". What you LOLngs don;t understand at all is that there is no money and there is no contingency for money and therefore no "plan" can be executed. No one knows how an arbiter might rule and there are no partnerships possible at all for several years at least. Arman has told you repeatedly that there won;t be any partnership interest until they can complete a new trial and show unequivocal results. NO ONE partners with a company whose management team consists of 3 pharma people who have never managed a trial together. NO ONE partners with a company with as much as $100,000,000 subject to injunctive relief. Those 2 matters are 1000% disqualifying. Big pharma absolutely throws money at bad prospects all the time, but they aren;t going to purposely burn their money or flush it down the toilet.
the raise was at 9 cents per share. you don;t know how to do the math on the private placement. that is beyond the capacity of LOLngs. they are raising $15m net with a full warrant sweetener and a 12% cash fee and a 13% gift of cashless warrants (each backed by a share, get it?) to paulson. figure that out and it comes to 169,000,000 shares no longer available and $15,000,000 raised. LESS THAN 9 cents per share raised.
you do understand that the FDA can reject cytodyn's hold release response, right? there isn't much expertise in dealing with such matters, as far as cytodyn employees are concerned. they could quite easily botch their submission.
This is why Cyrus is not CEO. he has no income. they are negotiating. he came on board and was granted 640k shares which are worth perhaps 150k and he is restricted regarding selling the shares and it hurts the share price if a ceo or president dumps their shares. but he needs money. he was also given options for 1.5m shares at .58 which may never be seen again. so the dude has had ZERO INCOME for 7 months, and has no way to generate income without renegotiating now and getting paid in cash. like a man, you know? so cytodyn has no money, and cyrus is looking to get paid - probably handsomely - and both the board and cyrus are backed into corners. he can't pay his mortgage, and they need a sucker to run the company as they move closer to bankruptcy. and he likely wants to leave rather than be the guy that presided over a bankruptcy, but again, he needs to pay his mortgage.
partnership is impossible at this time, for many reasons. most importantly, because the company has perhaps $100,000,000 past due that is subject to injunctive relief. that means if someone gave cytodyn $100,000,000 today, all of it could be taken away by the courts, and the assets would be frozen pending those decisions. cytodyn has no partners, no pending data, no active trials, no protocols submitted for trials, no money to run a trial. they are still banned from public sale of shares, and no lenders will touch them with all the past due debt they have. all they have left for fundraising is private placement and all they can raise with their remaining shares is about $20m. so they need more shares approved and they need the share price to move up substantially to cash in sufficiently with those shares. but they are down to just 1 potential positive catalyst - MD Anderson. nothing else.
company is 100% flat broke, according to filings. they initiated a private placement during the first 9 days of january. start date to purchase shares could have been 2 weeks later, perhaps as late as the 23rd - based upon the last couple cydy placement schedules. Form D is required within 15 calendar days of the first sale of securities as part of a placement, so i suppose its still potentially early to be looking for that. cytodyn has waited until day 14 or 15 in the past. ONE THING FOR SURE... they completely ran out of money this month and have not reported any new money raised. Form D would report the amount raised from the first day of selling shares from the placement. ITS GETTING UGLY. there may or may not be sufficient demand to raise the $15m that Is intended. 13 months ago they attempted to raise $50m and only raised $11m. last april they attempted to raise $20m and they were successful, but it took nearly three months. if they do raise the $15m, that will last until perhaps june. and they will have less than 75m shares remaining for any further raise. 75m shares at these prices, based upon cytodyn previous placement structure and fees, would only raise something like $8m. THEY HAVE $80,000,000 PAST DUE DEBT. they need $30,000,000 to pay bills thru end of 2024. and if they want to run a trial some day, they need $20,00,000 and then many more millions to staff up properly, as they have laid off 50% of the employees to reduce costs. they also have growing legal costs. and they have now been sued by at least one creditor. the only potential path out of this is via a publication by MD Anderson of very good keytruda-leronlimab combo mouse studies. there are no other potential catalysts prior to 2025 (OHSU HIV monkey studies) and 2025 is too late. they apparently just missed their 7TH DEADLINE for the amarex bond as well.
cytodyn has ZERO CASH ON HAND. they need $85,000,000 to pay down PAST DUE debt and they need $30,000,000 to keep the lights on. they also seem likely to have mounting legal fees. and if they want to hire a CMO CTO or other employees needed to replace those who have departed, that will cost additional millions. they certainly do not, and will not, have any money for a trial. and because they have nearly $100,000,000 in past due debt subject to injunctive relief, there will not be any partnership. zero patients dosed leronlimab in 2022 and zero patients will be dosed in 2023. aside from all that, they have no path to any potential approval until at least 2030.
the risk side of the equation: video
earliest possible eua for leron s/c will be q4.
only 1 trial planned - brazil.
india NOTHING yet
brazil meanwhile no start date
is the brazil protocol completed?
first week of march cd12 failure was shared
first week april cytodyn apparently lied about submitting a CD16 protocol to the US FDA. month and a half later and the brazil trial still not approved to begin.
40% fully vaccinated in the u.s.
stabilized at 2 million shots per day
states like ohio bribing trumpies to get vaccinated
entire world cases dropping
only a handful of countries getting worse, in asia
more and more vaccinated worldwide every day
still more vaccines to come to market
pandemic will be over by the end of the year
brazil trial 6 months from approval, no start date. what else is coming soon? phase 2 long haul data in july or august? phase 2 nash data? those need to be explosive in order to resurrect the share price. philippines a dead end. india no trial announcement yet. cydy is running out of shots on goal fast
sadly hiv is cytodead and everything else is 5 years off. except long haul. long haul requires a BLA, so thats years off in cytodyn world. hiv bla cant be done as they have a dosing data issue that requires a new trial. the receptor occupancy thing is swerious but a distraction from the bigger issue. hence the reason the havent even worked on the bla and the RO. they are aware that an added ph3 trial is needed, at least.
both the dosing and 65 year olds were the fault of amarex and cytodyn and no one else. the fda doesnt run the trials. the fda doesnt enroll. the fda doesnt review your trial for mistakes along the way. when you are ready to roll they approve or deny your protocol. when you are done they look at your data. and maybe an interim with extremely limited agenda in between. you are stating offbase conspiracy theories only
the dosing was part of cytodyn's protocol design. he fda doesnt write the protocols. you cant wait until an interim and then start changing your dosing. any discussion regarding the 2 vs 4 dosing is just perpetuating foolish conspiracy theories in defense of failed management
lol "Pawson" is opti scammer, not "Parsons"
The connection is same address for SPZI and 141 capital. 141 capital is a garrett parsons shell. garrett parsons was ceo at aitx b4 reinharz took over to execute the scam there.
29 s. lasalle st
suite 333
chicago
Parsons not Reinharz. Old scammer not new scammer. So the supposed aitx connection is actually via Parsons (former aitx ceo) who has a deeper scammer history than reinharz. reinharz is his protege, running the scam for him at aitz now. parsons name was too damaged for him to remain as ceo and execute the scam properly. parsons is using his 141 capital shell again and making spzi his new central scam. career stock pump n dump CEOs never quit. they rinse and repeat because its just too lucrative, too easy, and the potential sanctions unlikely and a slap in the wrist regardless in most instances.
ha, tbh, as i digest this... its an absolutely genius move. and i don;t mind making money on a scam. i'll look for this to calm down and buy in either way, ride the pump.
lol, so the scammer sees the end is near with his photoshop operation at aitx and he is positioning himself for an all new pump n dump and winning here already for sure. classic
the usual FAKE PR today from OZSC. lifted the info from a december PR naming the actual project participants. added a reference to scam partner GEMM. haha best part is ozsc only claimed was that they are a "purchasing agent". geez folks, even if you wanna believe the fake PR it still isnt worth 5% never mind 40% swing. look at GEMM website. they claim THREE PROJECTS IN 20 YEARS. and when u read their project blurbs... wow... not much there... it is apparent that MAYBE 1 of the projects was real. the 3rd listed they don't even claim happened. the 2nd listed is just generalities about a project by someone that perhaps happened. the first i didnt even bother checking, 20 years old. they make the hardest pitch on that one as its listed first on the page. likely fake as well.
SCAM: PR from ACTUAL project, NOT OZSC of course
https://md-pace.com/office-building-in-hanover-maryland-accesses-3-7-million-in-c-pace-financing-for-near-net-zero-energy-project/
yes and why didnt foote say something like that on tv!?
"HMBL puts your BANK in your Pocket!"
24,000,000 share block trade nice